Timber Hill’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-7,497
Closed -$1.23M 658
2017
Q4
$1.23M Buy
+7,497
New +$1.35M 0.08% 240
2017
Q1
Sell
-8,029
Closed -$1.87M 2487
2016
Q4
$1.69M Buy
+8,029
New +$1.66M 0.01% 997
2016
Q1
Sell
-27,746
Closed -$7.94M 2433
2015
Q4
$8.67M Buy
+27,746
New +$8.26M 0.04% 362
2015
Q2
Sell
-1,099
Closed -$328K 2691
2015
Q1
$327K Buy
+1,099
New +$313K ﹤0.01% 1999
2013
Q4
Sell
-8,748
Closed -$1.37M 3320
2013
Q3
$1.26M Buy
+8,748
New +$1.17M ﹤0.01% 1789

Other funds holding AGN

Timber Hill's AGN Position: Q1 2018 in Review

Timber Hill sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 7,497 shares — an estimated $1.23M sold.

Timber Hill first reported a position in AGN in Q3 2013 and held it in 5 quarters. The position peaked at $8.67M in Q4 2015. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Timber Hill reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Timber Hill sold 7,497 Allergan plc shares in Q1 2018, an estimated $1.23M.
  • Timber Hill first reported a position in Allergan plc in Q3 2013 and held it in 5 quarters.
  • Timber Hill's Allergan plc position peaked at $8.67M in Q4 2015.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Timber Hill's 13F filing for Q1 2018, filed 8 May 2018.